Literature DB >> 1665350

Autologous bone marrow transplantation for CML in which retroviral markers are used to discriminate between relapse which arises from systemic disease remaining after preparative therapy versus relapse due to residual leukemia cells in autologous marrow: a pilot trial. The University of Texas M.D. Anderson Cancer Center.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1665350     DOI： 10.1089/hum.1991.2.4-359

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  5 in total

Review 1.  Gene-marking studies of hematopoietic cells.

Authors:  C M Bollard; H E Heslop; M K Brenner
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

Review 2.  Genetic engineering: moral aspects and control of practice.

Authors:  V H Eisenberg; J G Schenker
Journal:  J Assist Reprod Genet       Date:  1997-07       Impact factor: 3.412

Review 3.  Human cancer and gene therapy.

Authors:  G Schmidt-Wolf; I G Schmidt-Wolf
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

Review 4.  Viral vectors for gene transfer: a review of their use in the treatment of human diseases.

Authors:  W Walther; U Stein
Journal:  Drugs       Date:  2000-08       Impact factor: 11.431

5.  Gene Therapy for Pediatric Cancer: State of the Art and Future Perspectives.

Authors:  Ettore Biagi; Catherine Bollard; Raphael Rousseau; Malcolm Brenner
Journal:  J Biomed Biotechnol       Date:  2003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.